Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Sickle Cell Disease Visiting Professorship Program

Pfizer Inc.

This competitive program seeks to provide financial support to organizations with limited SCD-focused resources and experience to host and coordinate a medical education program at their organization. The program should be led by a Visiting Professors of their choosing with expertise matched to the organization‚s unmet educational needs surrounding the management of Sickle Cell Disease.

• It is our intent to support opportunities for an institution to host a Sickle Cell Disease healthcare provider expert (”Expert„) to foster educational exchanges with local healthcare providers who can benefit from the Expert‚s knowledge and on-site presence.

• Expert should focus on educating Host Institution to establish coordinated care for individuals living with sickle cell disease beyond acute care service.

• Applicants should highlight educational gaps and describe how the selected Expert will address them during the visit.

• Priority will be given to plans that include robust opportunities for the Expert to interact with healthcare providers at the host organization beyond the lecture format. The organization responding to this posting and requesting the grant funding should be the organization ready to identify, invite, and host the Expert.

Deadline: June 12, 2025

Specialties

Curriculum Development

Medical - Clinical Science

Medical

Eligibility Requirements

Geographic Scope/Location of Project: United States

• The following may apply: medical and/or nursing professional schools; healthcare institutions (both large and small); professional organizations/medical societies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society). • If the project involves multiple departments within an institution and/or between different institutions /organizations/associations, all institutions must have a relevant role and the requesting organization must have a key role in the project. • The applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead‚s grant coordinator). • The project/program lead must be an employee or contractor of the requesting organization. • For projects offering continuing education credit, the requesting organization must be accredited.

Sponsor Details

Sponsor Institute/Organizations: Pfizer Inc.

Sponsor Type:

Address: 66 Hudson Boulevard East New York, NY 10001-2192 USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity